Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes.
Animal research · 2020
- What was studied
- Mice with dextran-sodium-sulphate-induced colitis
- Main finding
- Gepon reduced experimental colitis manifestations, inflammatory-cell infiltration and selected inflammatory gene signals.
Study data at a glance
- Participants or experimental model
- Mice with dextran-sodium-sulphate-induced colitis
- Reported results
- Gepon reduced experimental colitis manifestations, inflammatory-cell infiltration and selected inflammatory gene signals.
Study limitations and source details
Study limitations
- A chemically induced mouse model does not establish benefit or safety in human ulcerative colitis.
- Full methods, reporting completeness and independent replication remain to be appraised.
Source details
Original journal report
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Abstract reviewed
Sources checked
Citation
Chulkina MM, Pichugin AV, Ataullakhanov RI. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes. Peptides · PMID 32621844
Study source ↗ · DOI 10.1016/j.peptides.2020.170364 · Bibliography entry · Link to this summary